CD40LG and COVID-19: The current study found that approximately 4% of seropositive individuals were anti-nucleocapsid protein IgM positive, and a history of COVID-19 diagnosis was relatively common in the participants who had positive anti-N IgM and anti-N IgG than in the other groups.